There was a trend toward a reduced incidence of new-onset diabetes compared with placebo after 3 years of follow-up; however, this did not reach statistical significance.
← all excerpts
The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus.
1
—
—